Article Details
Retrieved on: 2024-05-31 21:10:25
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche's PI3K inhibitor wins FDA priority review for breast cancer. Paliouras said: “[These] two drugs, which have a novel mechanism of action ...
Article found on: www.pharmaceutical-technology.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here